TRE in Type 2 Diabetes (See Food Study 3)

Completed · Not applicable

Conditions studied: Type2Diabetes

In brief

Hyperglycemia in patients with Type 2 Diabetes Mellitus is initially treated with metformin coupled with intentional caloric restriction, which is difficult to sustain due to multiple barriers, including acquiring the necessary knowledge, teaching the intervention, cost of delivery and potential burden on quality of life. In contrast to intentionally restricting calories, time restricted eating (TRE), presents a simplified view of eating focused on restricting the eating window, which allows ad libitum intake per a person's dietary preferences during a daily fixed eating window. This study proposes a 24 week feasibility study to test if TRE is a viable alternative to Caloric Restriction in improving glycemic measures while accounting for weight loss in overweight/obese patients \[BMI:25-45 kg/m2\] with metformin-only treated Type 2 diabetes.

Key facts

Study ID

NCT05290246

Run by

University of Minnesota

People needed

115

Starts

2022-05-27

Expected to finish

2026-03-23

Last updated by the study team

2026-04-14

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Overweight/obese adults with metformin-only treated type 2 diabetes
• 18-65 years old
• BMI:25-45 kg/m2
• HbA1c: 6.5-8.5%
• Self-reported weight must be stable [±5 pounds] for at least 3 months prior to the study
• Owns a smartphone.

You may not qualify if…

• Active or anticipated pregnancy during the study
• type 2 diabetes treated with medications other than metformin
• presence of eating disorders as noted by screening survey.

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.